![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMiD) drug and an anti-CD38 monoclonal antibody...
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMiD) drug and an anti-CD38 monoclonal antibody...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.82 | 8.85053250092 | 54.46 | 60.24 | 53 | 348098 | 55.98504225 | CS |
4 | 4.36 | 7.93882010197 | 54.92 | 60.24 | 52.205 | 443187 | 54.73570206 | CS |
12 | 5.92 | 11.0944527736 | 53.36 | 60.24 | 47.88 | 461015 | 52.97157628 | CS |
26 | 4.99 | 9.19137962792 | 54.29 | 75.1 | 47.88 | 450396 | 58.95927021 | CS |
52 | 25.48 | 75.3846153846 | 33.8 | 75.1 | 30.88 | 520026 | 49.69587272 | CS |
156 | 40.28 | 212 | 19 | 75.1 | 6.035 | 471192 | 37.3231791 | CS |
260 | 40.28 | 212 | 19 | 75.1 | 6.035 | 471192 | 37.3231791 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions